臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shao y y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 181-205 / 396 (共16頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-08-10T03:53:02Z	A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma	SHIH-HUNG YANG; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2021-07-23T07:49:44Z	Right or left? Side selection for a totally implantable vascular access device: A randomised observational study	WEN-YING LIN; Lin C.-P.; Hsu C.-H.; Lee Y.-H.; Lin Y.-T.; Hsu M.-C.; Shao Y.-Y.
臺大學術典藏	2021-07-23T07:49:43Z	Solving the deficit of cancer pain management skills by education programs	Shao Y.-Y.; WEN-YING LIN; Lin C.-P.; Lu L.-C.; Hsu C.-H.
臺大學術典藏	2021-07-12T08:46:25Z	�]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma	Lu L.-C.; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; HSIANG-FONG KAO; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-07-03T03:34:48Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; PEI-JER CHEN; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-07-03T03:33:48Z	Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study	Lu L.-C.; PEI-JER CHEN; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏	2021-06-04T06:23:10Z	Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS	Chiu H.-H.; Liao H.-W.; Shao Y.-Y.; Lu Y.-S.; Lin C.-H.; Tsai I.-L.; CHING-HUA KUO
臺大學術典藏	2021-06-01T07:03:09Z	Key opioid prescription concerns in cancer patients: A nationwide study	Lin C.-P.; Hsu C.-H.; WEN-MEI FU; Chen H.-M.; Lee Y.-H.; Lai M.-S.; Shao Y.-Y.
臺大學術典藏	2021-05-27T09:07:06Z	Emergency department presentation of chronic peritoneal dialysis patients	Pai M.-F.; Hsu S.-P.; Peng Y.-S.; CHIH-KANG CHIANG; Ho T.-I.; Shao Y.Y.; Lee H.-Y.; Hung K.-Y.
臺大學術典藏	2021-05-07T06:02:30Z	Cytotoxic chemotherapy as first-line therapy for advanced non-small-cell lung cancer in Taiwan: Daily practice	Liang Y.-H.;Shao Y.-Y.;Liao B.-C.;Lee H.-S.;Yang J.C.-H.;Chen H.-M.;Chun-Ju Chiang;Cheng A.-L.;Lai M.-S.; Liang Y.-H.; Shao Y.-Y.; Liao B.-C.; Lee H.-S.; Yang J.C.-H.; Chen H.-M.; CHUN-JU CHIANG; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2021-05-07T02:46:37Z	Young patients with colorectal cancer have increased risk of second primary cancers	YI-HSIN LIANG; Shao Y.-Y.; Chen H.-M.; Lai C.-L.; Lin Z.-Z.; Kuo R.N.; Cheng A.-L.; Yeh K.-H.; Lai M.-S.
臺大學術典藏	2021-05-07T02:46:36Z	Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study	YI-HSIN LIANG; Shao Y.-Y.; Chen H.-M.; Cheng A.-L.; Lai M.-S.; Yeh K.-H.
臺大學術典藏	2021-05-07T02:46:36Z	Cytotoxic chemotherapy as first-line therapy for advanced non-small-cell lung cancer in Taiwan: Daily practice	YI-HSIN LIANG; Shao Y.-Y.; Liao B.-C.; Lee H.-S.; Yang J.C.-H.; Chen H.-M.; Chiang C.-J.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2021-05-07T02:46:34Z	Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer	YI-HSIN LIANG; Wei C.-H.; Hsu W.-H.; Shao Y.-Y.; Lin Y.-C.; Chou P.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2021-05-03T02:21:08Z	Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions	Shao Y.-Y.; Hu F.-C.; JIN-TUNG LIANG; Chiu W.-T.; Cheng A.-L.; Yang C.-H.
臺大學術典藏	2021-04-27T08:36:02Z	The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia	HUNG-YANG KUO; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; Cheng W.-F.; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏	2021-04-27T08:36:01Z	Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors	Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏	2021-04-27T08:11:51Z	The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia	HUNG-YANG KUO; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; Cheng W.-F.; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏	2021-04-27T08:11:50Z	Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors	Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏	2021-04-26T01:47:25Z	Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan	Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; MING-CHIH HO; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏	2021-03-19T01:54:21Z	Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma	Shao Y.-Y.; TSUNG-HAO LIU; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-19T01:54:20Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	TSUNG-HAO LIU; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-19T01:54:20Z	Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure	TSUNG-HAO LIU; Hsu C.-H.; Shao Y.-Y.
臺大學術典藏	2021-03-19T01:54:20Z	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; TSUNG-HAO LIU; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-03-19T01:54:19Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.; TSUNG-HAO LIU; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.

顯示項目 181-205 / 396 (共16頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 53288679 線上人數 : 748 教育部委託研究計畫計畫執行:國立臺灣大學圖書館